Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
3 Jun 22
DEFC14A
Proxy in contested solicitation
29 Apr 22
PRRN14A
Revised preliminary proxy statement filed by non-management
27 Apr 22
PRRN14A
Revised preliminary proxy statement filed by non-management
25 Apr 22
CORRESP
Correspondence with SEC
25 Apr 22
PREC14A
Preliminary proxy with contested solicitation
11 Apr 22
D/A
$740.3M in investment fund / equity, sold $740.3M
20 Jan 17
D
$600M in investment fund / equity
1 Apr 16
Latest ownership filings
4
PETER THIEL
8 Feb 24
3
PETER THIEL
1 Feb 24
SC 13D/A
BlackSky Technology Inc.
20 Apr 23
SC 13D/A
Adagio Therapeutics, Inc.
5 Jul 22
SC 13D/A
Adagio Therapeutics, Inc.
24 Jun 22
SC 13D/A
Adagio Therapeutics, Inc.
25 Apr 22
4
PETER THIEL
30 Mar 22
SC 13D/A
Adagio Therapeutics, Inc.
30 Mar 22
3
PETER THIEL
20 Sep 21
SC 13D
BlackSky Technology Inc.
20 Sep 21